LARP4 Protein Drives T Cell Exhaustion in Cancer Through Mitochondrial Dysfunction

This groundbreaking study reveals a key mechanism behind why T cells become exhausted and ineffective when fighting tumors, potentially opening new avenues for improving cancer immunotherapy. Researchers identified LARP4, an RNA-binding protein, as a critical driver of T cell dysfunction in the tumor microenvironment.

The team discovered that T cells infiltrating tumors undergo dramatic changes in protein production, entering what they term a 'hypertranslational state.' LARP4 orchestrates this process by selectively boosting translation of genes involved in oxidative phosphorylation (OXPHOS), the cellular process that generates energy in mitochondria. This selective enhancement creates an imbalance in mitochondrial protein components, ultimately disrupting the cell's energy production systems.

When researchers knocked out LARP4 in tumor-specific CD8+ T cells, the results were striking. These modified T cells showed reduced hypertranslation, restored mitochondrial function, decreased exhaustion markers, and enhanced persistence within tumors. Most importantly, this led to significantly improved anti-tumor responses. The team also demonstrated that reducing LARP4 in CAR-T cells prevented terminal exhaustion and improved responses against both liquid and solid tumors.

These findings suggest that targeting LARP4 could enhance existing immunotherapies by maintaining T cell function longer in hostile tumor environments. The research highlights how protein translation dysregulation contributes to immune dysfunction, offering a new therapeutic target for cancer treatment.